TTK Healthcare Reports FY26 Results

TTK Healthcare's revenue grew to ₹857.28 crore for the fiscal year ended March 31, 2026, a 6.96% increase from ₹801.49 crore in the previous year. However, net profit saw a decline of 19.57%, falling to ₹65.68 crore from ₹81.66 crore in FY 2025.

Reader Takeaway: Revenue grew, but profit fell due to exceptional charges and segment losses.

What just happened

TTK Healthcare announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a consolidated revenue from operations of ₹857.28 crore. Net profit after tax stood at ₹65.68 crore.
The Board recommended a dividend of ₹10 per equity share. Mr. T T Raghunathan was reappointed as Executive Chairman for a five-year term.

Why this matters

The profit decline, despite revenue growth, is a key concern for investors. The decrease was largely due to exceptional items, including a net charge of ₹4.07 crore in FY26 related to the implementation of new Labour Codes. In contrast, FY25 had recorded an exceptional gain of ₹13.91 crore. This difference significantly impacts year-on-year profit comparison.

The backstory

In the previous fiscal year (FY 2025), TTK Healthcare had reported a net profit of ₹81.66 crore on revenues of ₹801.49 crore. The company's performance in FY26 was influenced by factors that led to an overall profit decrease. The reappointment of Mr. T T Raghunathan ensures leadership continuity.

What changes now

Shareholders will receive a dividend of ₹10 per equity share, subject to approval. The company's financial reporting will continue to reflect the adjustments arising from new labour regulations, which may also impact wage structures in the upcoming fiscal year.

The 'Protective Devices' segment reported a loss of ₹10.54 crore, a point to monitor for future performance improvement.

Risks to watch

Ongoing adjustments related to new Labour Codes could continue to affect wage structures and accounting. The profitability of the 'Protective Devices' segment remains a concern that could impact overall financial health.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

• Revenue Growth: FY 2026 revenue increased by 6.96% to ₹857.28 crore from ₹801.49 crore in FY 2025.
• Profit Decline: Net profit decreased by 19.57% to ₹65.68 crore in FY 2026 from ₹81.66 crore in FY 2025.
• Dividend: A dividend of ₹10 per share (100%) is recommended for FY 2026.
• Executive Chairman Term: Reappointment for 5 years from November 01, 2026.

What to track next

Investors should closely monitor the company's ability to manage the impact of the new Labour Codes and improve profitability in the 'Protective Devices' segment in the coming quarters. The company's operational performance and segment-specific results will be key indicators.